Jack A. Khattar, President, CEO at SUPERNUS PHARMACEUTICALS, INC. (SUPN), sold 27,264 shares at $42.06 ($1.1M) on 2023-02-02, disclosed to the SEC on 2023-02-06.
Open-market sale of $1.1M SUPN by President, CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $42.06 | 13,532 | $569K | 49.6% |
| 2 | $42.06 | 13,532 | $569K | 49.6% |
| 3 | $42.02 | 200 | $8K | 0.7% |
| Total | $42.06 avg | 27,264 | $1.1M | 100% |
| Filing → |
| SUPN | SELL | 2025-10-03 | $183K | — | Filing → |
| SUPN | SELL | 2025-10-02 | $3.9M | — | Filing → |
| SUPN | SELL | 2025-10-01 | $414K | — | Filing → |